nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—Nateglinide—Lacosamide—epilepsy syndrome	0.291	1	CrCrCtD
Cilazapril—ABCB1—epilepsy syndrome	0.163	1	CbGaD
Cilazapril—ABCB1—Levetiracetam—epilepsy syndrome	0.05	0.208	CbGbCtD
Cilazapril—ABCB1—Clobazam—epilepsy syndrome	0.0347	0.144	CbGbCtD
Cilazapril—ABCB1—Lamotrigine—epilepsy syndrome	0.0334	0.139	CbGbCtD
Cilazapril—ABCB1—Carbamazepine—epilepsy syndrome	0.0287	0.12	CbGbCtD
Cilazapril—ABCB1—Phenytoin—epilepsy syndrome	0.0258	0.107	CbGbCtD
Cilazapril—ABCB1—Phenobarbital—epilepsy syndrome	0.023	0.0957	CbGbCtD
Cilazapril—ABCB1—Midazolam—epilepsy syndrome	0.0226	0.0944	CbGbCtD
Cilazapril—ABCB1—Diazepam—epilepsy syndrome	0.0218	0.0907	CbGbCtD
Cilazapril—ACE—forelimb—epilepsy syndrome	0.00329	0.194	CbGeAlD
Cilazapril—ACE—autonomic nervous system—epilepsy syndrome	0.0032	0.188	CbGeAlD
Cilazapril—ACE—ganglion—epilepsy syndrome	0.00178	0.105	CbGeAlD
Cilazapril—ACE—forebrain—epilepsy syndrome	0.000746	0.0439	CbGeAlD
Cilazapril—Mitiglinide—KCNJ11—epilepsy syndrome	0.00074	0.234	CrCbGaD
Cilazapril—ACE—telencephalon—epilepsy syndrome	0.000686	0.0403	CbGeAlD
Cilazapril—Enalapril—SLCO1A2—epilepsy syndrome	0.000624	0.198	CrCbGaD
Cilazapril—SLC15A2—telencephalon—epilepsy syndrome	0.000598	0.0352	CbGeAlD
Cilazapril—ACE—spinal cord—epilepsy syndrome	0.00048	0.0283	CbGeAlD
Cilazapril—SLC15A2—medulla oblongata—epilepsy syndrome	0.00047	0.0276	CbGeAlD
Cilazapril—Perindopril—BCHE—epilepsy syndrome	0.000433	0.137	CrCbGaD
Cilazapril—SLC15A2—midbrain—epilepsy syndrome	0.000429	0.0253	CbGeAlD
Cilazapril—ACE—head—epilepsy syndrome	0.000427	0.0251	CbGeAlD
Cilazapril—SLC15A2—spinal cord—epilepsy syndrome	0.000419	0.0246	CbGeAlD
Cilazapril—ACE—nervous system—epilepsy syndrome	0.000405	0.0238	CbGeAlD
Cilazapril—ACE—central nervous system—epilepsy syndrome	0.00039	0.0229	CbGeAlD
Cilazapril—Nateglinide—KCNJ11—epilepsy syndrome	0.000377	0.119	CrCbGaD
Cilazapril—SLC15A2—head—epilepsy syndrome	0.000372	0.0219	CbGeAlD
Cilazapril—Ramipril—BCHE—epilepsy syndrome	0.00037	0.117	CrCbGaD
Cilazapril—SLC15A2—nervous system—epilepsy syndrome	0.000353	0.0208	CbGeAlD
Cilazapril—SLC15A2—central nervous system—epilepsy syndrome	0.00034	0.02	CbGeAlD
Cilazapril—SLC15A2—cerebellum—epilepsy syndrome	0.000332	0.0195	CbGeAlD
Cilazapril—ACE—brain—epilepsy syndrome	0.000309	0.0182	CbGeAlD
Cilazapril—SLC15A2—brain—epilepsy syndrome	0.00027	0.0159	CbGeAlD
Cilazapril—ABCB1—forebrain—epilepsy syndrome	0.000263	0.0154	CbGeAlD
Cilazapril—ABCB1—telencephalon—epilepsy syndrome	0.000241	0.0142	CbGeAlD
Cilazapril—ACE—Metabolism of proteins—ERN1—epilepsy syndrome	0.000221	0.00404	CbGpPWpGaD
Cilazapril—ABCB1—ABC-family proteins mediated transport—ABCC2—epilepsy syndrome	0.000213	0.0039	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.000207	0.00379	CbGpPWpGaD
Cilazapril—ABCB1—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	0.000206	0.00377	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000202	0.00369	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000202	0.00369	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.0002	0.00366	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.0002	0.00366	CbGpPWpGaD
Cilazapril—ACE—Peptide hormone metabolism—POMC—epilepsy syndrome	0.000199	0.00365	CbGpPWpGaD
Cilazapril—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	0.000194	0.00356	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.000192	0.00352	CbGpPWpGaD
Cilazapril—ABCB1—medulla oblongata—epilepsy syndrome	0.00019	0.0112	CbGeAlD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—NT5E—epilepsy syndrome	0.00019	0.00347	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000187	0.00343	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000187	0.00343	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000186	0.0034	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000186	0.0034	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000184	0.00338	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—NEU1—epilepsy syndrome	0.00018	0.0033	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—EIF2AK3—epilepsy syndrome	0.00018	0.0033	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000178	0.00327	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000178	0.00327	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000178	0.00327	CbGpPWpGaD
Cilazapril—ABCB1—midbrain—epilepsy syndrome	0.000173	0.0102	CbGeAlD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000171	0.00314	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000171	0.00313	CbGpPWpGaD
Cilazapril—Perindopril—ABCB1—epilepsy syndrome	0.00017	0.0538	CrCbGaD
Cilazapril—ABCB1—spinal cord—epilepsy syndrome	0.000169	0.00995	CbGeAlD
Cilazapril—ACE—Metabolism of proteins—PIGA—epilepsy syndrome	0.000167	0.00306	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—TPP1—epilepsy syndrome	0.000167	0.00306	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000166	0.00303	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000166	0.00303	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000166	0.00303	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000163	0.00299	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000159	0.00291	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—EIF2B5—epilepsy syndrome	0.000157	0.00288	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000151	0.00277	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000151	0.00276	CbGpPWpGaD
Cilazapril—ABCB1—head—epilepsy syndrome	0.00015	0.00884	CbGeAlD
Cilazapril—Lisinopril—ABCB1—epilepsy syndrome	0.00015	0.0474	CrCbGaD
Cilazapril—ACE—Metabolism of proteins—ADD1—epilepsy syndrome	0.000149	0.00273	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000146	0.00267	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000143	0.00261	CbGpPWpGaD
Cilazapril—ABCB1—nervous system—epilepsy syndrome	0.000143	0.00838	CbGeAlD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—epilepsy syndrome	0.000142	0.00259	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.00014	0.00256	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—GDNF—epilepsy syndrome	0.00014	0.00255	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—ST3GAL3—epilepsy syndrome	0.000139	0.00255	CbGpPWpGaD
Cilazapril—ABCB1—central nervous system—epilepsy syndrome	0.000137	0.00807	CbGeAlD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000135	0.00248	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000135	0.00248	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000135	0.00248	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000135	0.00248	CbGpPWpGaD
Cilazapril—ABCB1—cerebellum—epilepsy syndrome	0.000134	0.00789	CbGeAlD
Cilazapril—ACE—Metabolism of proteins—ST3GAL5—epilepsy syndrome	0.000134	0.00245	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000132	0.00242	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.00013	0.00238	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000129	0.00236	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000129	0.00236	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—ATP6AP2—epilepsy syndrome	0.000127	0.00232	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000126	0.0023	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000126	0.0023	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000126	0.0023	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—epilepsy syndrome	0.000122	0.00223	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000121	0.00221	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.00012	0.00219	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.00012	0.00219	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	0.000118	0.00216	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—ABCG2—epilepsy syndrome	0.000112	0.00204	CbGpPWpGaD
Cilazapril—Enalapril—ABCB1—epilepsy syndrome	0.00011	0.0348	CrCbGaD
Cilazapril—ABCB1—brain—epilepsy syndrome	0.000109	0.00641	CbGeAlD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000105	0.00193	CbGpPWpGaD
Cilazapril—Nateglinide—CYP2D6—epilepsy syndrome	0.000105	0.0333	CrCbGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000102	0.00188	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000102	0.00188	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	9.78e-05	0.00179	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	9.76e-05	0.00179	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—EPO—epilepsy syndrome	9.58e-05	0.00175	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	9.51e-05	0.00174	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	9.51e-05	0.00174	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	9.4e-05	0.00172	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	9.37e-05	0.00172	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	9.37e-05	0.00172	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	9.37e-05	0.00172	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	9.37e-05	0.00172	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—NTF3—epilepsy syndrome	9.09e-05	0.00166	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	9.07e-05	0.00166	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—CXCL12—epilepsy syndrome	8.93e-05	0.00163	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—epilepsy syndrome	8.83e-05	0.00162	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	8.72e-05	0.0016	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	8.71e-05	0.0016	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	8.7e-05	0.00159	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	8.7e-05	0.00159	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	8.7e-05	0.00159	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	8.7e-05	0.00159	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—EIF2S1—epilepsy syndrome	8.57e-05	0.00157	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CAPN1—epilepsy syndrome	8.54e-05	0.00156	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—ACTB—epilepsy syndrome	8.47e-05	0.00155	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	8.31e-05	0.00152	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	8.19e-05	0.0015	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	8.09e-05	0.00148	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	7.97e-05	0.00146	CbGpPWpGaD
Cilazapril—Nateglinide—ALB—epilepsy syndrome	7.86e-05	0.0249	CrCbGaD
Cilazapril—ABCB1—Allograft Rejection—CXCL12—epilepsy syndrome	7.73e-05	0.00142	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	7.72e-05	0.00141	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	7.67e-05	0.0014	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	7.66e-05	0.0014	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CD40—epilepsy syndrome	7.65e-05	0.0014	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	7.6e-05	0.00139	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	7.41e-05	0.00136	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	7.41e-05	0.00136	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	7.4e-05	0.00135	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—BCHE—epilepsy syndrome	7.29e-05	0.00133	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—HMOX1—epilepsy syndrome	7.26e-05	0.00133	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	7.12e-05	0.0013	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	7.11e-05	0.0013	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	7.1e-05	0.0013	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	6.88e-05	0.00126	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	6.88e-05	0.00126	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	6.6e-05	0.00121	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	6.59e-05	0.00121	CbGpPWpGaD
Cilazapril—Dermatitis—Vigabatrin—epilepsy syndrome	6.57e-05	0.000285	CcSEcCtD
Cilazapril—Urethral disorder—Topiramate—epilepsy syndrome	6.57e-05	0.000285	CcSEcCtD
Cilazapril—Pruritus—Oxcarbazepine—epilepsy syndrome	6.55e-05	0.000284	CcSEcCtD
Cilazapril—Hypersensitivity—Carbamazepine—epilepsy syndrome	6.55e-05	0.000284	CcSEcCtD
Cilazapril—Headache—Vigabatrin—epilepsy syndrome	6.53e-05	0.000283	CcSEcCtD
Cilazapril—Hypertension—Pregabalin—epilepsy syndrome	6.53e-05	0.000283	CcSEcCtD
Cilazapril—Vomiting—Diazepam—epilepsy syndrome	6.53e-05	0.000283	CcSEcCtD
Cilazapril—Anorexia—Valproic Acid—epilepsy syndrome	6.5e-05	0.000282	CcSEcCtD
Cilazapril—Tremor—Gabapentin—epilepsy syndrome	6.49e-05	0.000282	CcSEcCtD
Cilazapril—Rash—Diazepam—epilepsy syndrome	6.47e-05	0.000281	CcSEcCtD
Cilazapril—Dermatitis—Diazepam—epilepsy syndrome	6.47e-05	0.00028	CcSEcCtD
Cilazapril—Visual impairment—Topiramate—epilepsy syndrome	6.46e-05	0.00028	CcSEcCtD
Cilazapril—Myalgia—Pregabalin—epilepsy syndrome	6.44e-05	0.000279	CcSEcCtD
Cilazapril—Arthralgia—Pregabalin—epilepsy syndrome	6.44e-05	0.000279	CcSEcCtD
Cilazapril—Chest pain—Pregabalin—epilepsy syndrome	6.44e-05	0.000279	CcSEcCtD
Cilazapril—Ill-defined disorder—Gabapentin—epilepsy syndrome	6.43e-05	0.000279	CcSEcCtD
Cilazapril—Dizziness—Zonisamide—epilepsy syndrome	6.43e-05	0.000279	CcSEcCtD
Cilazapril—Headache—Diazepam—epilepsy syndrome	6.43e-05	0.000279	CcSEcCtD
Cilazapril—Anxiety—Pregabalin—epilepsy syndrome	6.41e-05	0.000278	CcSEcCtD
Cilazapril—Diarrhoea—Clonazepam—epilepsy syndrome	6.41e-05	0.000278	CcSEcCtD
Cilazapril—Anaemia—Gabapentin—epilepsy syndrome	6.41e-05	0.000278	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	6.39e-05	0.000277	CcSEcCtD
Cilazapril—Hypotension—Valproic Acid—epilepsy syndrome	6.38e-05	0.000277	CcSEcCtD
Cilazapril—Asthenia—Carbamazepine—epilepsy syndrome	6.37e-05	0.000277	CcSEcCtD
Cilazapril—Diarrhoea—Phenytoin—epilepsy syndrome	6.37e-05	0.000276	CcSEcCtD
Cilazapril—Discomfort—Pregabalin—epilepsy syndrome	6.36e-05	0.000276	CcSEcCtD
Cilazapril—Nausea—Fosphenytoin—epilepsy syndrome	6.35e-05	0.000276	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—PLAUR—epilepsy syndrome	6.34e-05	0.00116	CbGpPWpGaD
Cilazapril—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.34e-05	0.000275	CcSEcCtD
Cilazapril—Erythema multiforme—Topiramate—epilepsy syndrome	6.33e-05	0.000275	CcSEcCtD
Cilazapril—Angioedema—Gabapentin—epilepsy syndrome	6.33e-05	0.000275	CcSEcCtD
Cilazapril—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.33e-05	0.000274	CcSEcCtD
Cilazapril—Vomiting—Felbamate—epilepsy syndrome	6.32e-05	0.000274	CcSEcCtD
Cilazapril—Dry mouth—Pregabalin—epilepsy syndrome	6.29e-05	0.000273	CcSEcCtD
Cilazapril—Pruritus—Carbamazepine—epilepsy syndrome	6.29e-05	0.000273	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	6.28e-05	0.00115	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	6.28e-05	0.00115	CbGpPWpGaD
Cilazapril—Rash—Felbamate—epilepsy syndrome	6.26e-05	0.000272	CcSEcCtD
Cilazapril—Dermatitis—Felbamate—epilepsy syndrome	6.26e-05	0.000271	CcSEcCtD
Cilazapril—Malaise—Gabapentin—epilepsy syndrome	6.25e-05	0.000271	CcSEcCtD
Cilazapril—Tinnitus—Topiramate—epilepsy syndrome	6.25e-05	0.000271	CcSEcCtD
Cilazapril—Vertigo—Gabapentin—epilepsy syndrome	6.23e-05	0.00027	CcSEcCtD
Cilazapril—Headache—Felbamate—epilepsy syndrome	6.22e-05	0.00027	CcSEcCtD
Cilazapril—Confusional state—Pregabalin—epilepsy syndrome	6.22e-05	0.00027	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	6.22e-05	0.00027	CcSEcCtD
Cilazapril—Flushing—Topiramate—epilepsy syndrome	6.22e-05	0.00027	CcSEcCtD
Cilazapril—Cardiac disorder—Topiramate—epilepsy syndrome	6.22e-05	0.00027	CcSEcCtD
Cilazapril—Syncope—Gabapentin—epilepsy syndrome	6.22e-05	0.00027	CcSEcCtD
Cilazapril—Leukopenia—Gabapentin—epilepsy syndrome	6.2e-05	0.000269	CcSEcCtD
Cilazapril—Dizziness—Clonazepam—epilepsy syndrome	6.2e-05	0.000269	CcSEcCtD
Cilazapril—Nausea—Vigabatrin—epilepsy syndrome	6.19e-05	0.000269	CcSEcCtD
Cilazapril—Vomiting—Zonisamide—epilepsy syndrome	6.18e-05	0.000268	CcSEcCtD
Cilazapril—Insomnia—Valproic Acid—epilepsy syndrome	6.17e-05	0.000268	CcSEcCtD
Cilazapril—Oedema—Pregabalin—epilepsy syndrome	6.17e-05	0.000268	CcSEcCtD
Cilazapril—Asthenia—Lamotrigine—epilepsy syndrome	6.16e-05	0.000267	CcSEcCtD
Cilazapril—Dizziness—Phenytoin—epilepsy syndrome	6.16e-05	0.000267	CcSEcCtD
Cilazapril—Rash—Zonisamide—epilepsy syndrome	6.13e-05	0.000266	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	6.13e-05	0.00112	CbGpPWpGaD
Cilazapril—Paraesthesia—Valproic Acid—epilepsy syndrome	6.13e-05	0.000266	CcSEcCtD
Cilazapril—Palpitations—Gabapentin—epilepsy syndrome	6.13e-05	0.000266	CcSEcCtD
Cilazapril—Dermatitis—Zonisamide—epilepsy syndrome	6.13e-05	0.000266	CcSEcCtD
Cilazapril—Dizziness—Oxcarbazepine—epilepsy syndrome	6.12e-05	0.000266	CcSEcCtD
Cilazapril—Nausea—Diazepam—epilepsy syndrome	6.1e-05	0.000264	CcSEcCtD
Cilazapril—Loss of consciousness—Gabapentin—epilepsy syndrome	6.09e-05	0.000264	CcSEcCtD
Cilazapril—Headache—Zonisamide—epilepsy syndrome	6.09e-05	0.000264	CcSEcCtD
Cilazapril—Dyspnoea—Valproic Acid—epilepsy syndrome	6.08e-05	0.000264	CcSEcCtD
Cilazapril—Diarrhoea—Carbamazepine—epilepsy syndrome	6.08e-05	0.000264	CcSEcCtD
Cilazapril—Angiopathy—Topiramate—epilepsy syndrome	6.08e-05	0.000264	CcSEcCtD
Cilazapril—Pruritus—Lamotrigine—epilepsy syndrome	6.08e-05	0.000264	CcSEcCtD
Cilazapril—Shock—Pregabalin—epilepsy syndrome	6.07e-05	0.000263	CcSEcCtD
Cilazapril—Somnolence—Valproic Acid—epilepsy syndrome	6.07e-05	0.000263	CcSEcCtD
Cilazapril—Immune system disorder—Topiramate—epilepsy syndrome	6.05e-05	0.000262	CcSEcCtD
Cilazapril—Cough—Gabapentin—epilepsy syndrome	6.05e-05	0.000262	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	6.04e-05	0.00111	CbGpPWpGaD
Cilazapril—Thrombocytopenia—Pregabalin—epilepsy syndrome	6.04e-05	0.000262	CcSEcCtD
Cilazapril—Tachycardia—Pregabalin—epilepsy syndrome	6.02e-05	0.000261	CcSEcCtD
Cilazapril—Chills—Topiramate—epilepsy syndrome	6.01e-05	0.000261	CcSEcCtD
Cilazapril—Dyspepsia—Valproic Acid—epilepsy syndrome	6.01e-05	0.000261	CcSEcCtD
Cilazapril—Skin disorder—Pregabalin—epilepsy syndrome	5.99e-05	0.00026	CcSEcCtD
Cilazapril—Hypertension—Gabapentin—epilepsy syndrome	5.98e-05	0.00026	CcSEcCtD
Cilazapril—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.96e-05	0.000259	CcSEcCtD
Cilazapril—Vomiting—Clonazepam—epilepsy syndrome	5.96e-05	0.000258	CcSEcCtD
Cilazapril—Decreased appetite—Valproic Acid—epilepsy syndrome	5.93e-05	0.000257	CcSEcCtD
Cilazapril—Alopecia—Topiramate—epilepsy syndrome	5.92e-05	0.000257	CcSEcCtD
Cilazapril—Vomiting—Phenytoin—epilepsy syndrome	5.92e-05	0.000257	CcSEcCtD
Cilazapril—Rash—Clonazepam—epilepsy syndrome	5.91e-05	0.000256	CcSEcCtD
Cilazapril—Dermatitis—Clonazepam—epilepsy syndrome	5.9e-05	0.000256	CcSEcCtD
Cilazapril—Chest pain—Gabapentin—epilepsy syndrome	5.9e-05	0.000256	CcSEcCtD
Cilazapril—Myalgia—Gabapentin—epilepsy syndrome	5.9e-05	0.000256	CcSEcCtD
Cilazapril—Arthralgia—Gabapentin—epilepsy syndrome	5.9e-05	0.000256	CcSEcCtD
Cilazapril—Nausea—Felbamate—epilepsy syndrome	5.9e-05	0.000256	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.89e-05	0.000256	CcSEcCtD
Cilazapril—Vomiting—Oxcarbazepine—epilepsy syndrome	5.89e-05	0.000255	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	5.89e-05	0.00108	CbGpPWpGaD
Cilazapril—Fatigue—Valproic Acid—epilepsy syndrome	5.88e-05	0.000255	CcSEcCtD
Cilazapril—Anxiety—Gabapentin—epilepsy syndrome	5.88e-05	0.000255	CcSEcCtD
Cilazapril—Anorexia—Pregabalin—epilepsy syndrome	5.88e-05	0.000255	CcSEcCtD
Cilazapril—Dizziness—Carbamazepine—epilepsy syndrome	5.88e-05	0.000255	CcSEcCtD
Cilazapril—Diarrhoea—Lamotrigine—epilepsy syndrome	5.88e-05	0.000255	CcSEcCtD
Cilazapril—Headache—Clonazepam—epilepsy syndrome	5.87e-05	0.000255	CcSEcCtD
Cilazapril—Rash—Phenytoin—epilepsy syndrome	5.87e-05	0.000255	CcSEcCtD
Cilazapril—Dermatitis—Phenytoin—epilepsy syndrome	5.86e-05	0.000254	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.86e-05	0.000254	CcSEcCtD
Cilazapril—Rash—Oxcarbazepine—epilepsy syndrome	5.84e-05	0.000253	CcSEcCtD
Cilazapril—Constipation—Valproic Acid—epilepsy syndrome	5.84e-05	0.000253	CcSEcCtD
Cilazapril—Pain—Valproic Acid—epilepsy syndrome	5.84e-05	0.000253	CcSEcCtD
Cilazapril—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.83e-05	0.000253	CcSEcCtD
Cilazapril—Headache—Phenytoin—epilepsy syndrome	5.83e-05	0.000253	CcSEcCtD
Cilazapril—Discomfort—Gabapentin—epilepsy syndrome	5.83e-05	0.000253	CcSEcCtD
Cilazapril—Headache—Oxcarbazepine—epilepsy syndrome	5.8e-05	0.000252	CcSEcCtD
Cilazapril—Nausea—Zonisamide—epilepsy syndrome	5.78e-05	0.000251	CcSEcCtD
Cilazapril—Dry mouth—Gabapentin—epilepsy syndrome	5.77e-05	0.00025	CcSEcCtD
Cilazapril—Hypotension—Pregabalin—epilepsy syndrome	5.76e-05	0.00025	CcSEcCtD
Cilazapril—Flatulence—Topiramate—epilepsy syndrome	5.75e-05	0.000249	CcSEcCtD
Cilazapril—Tension—Topiramate—epilepsy syndrome	5.72e-05	0.000248	CcSEcCtD
Cilazapril—Dysgeusia—Topiramate—epilepsy syndrome	5.71e-05	0.000248	CcSEcCtD
Cilazapril—Confusional state—Gabapentin—epilepsy syndrome	5.7e-05	0.000247	CcSEcCtD
Cilazapril—Dizziness—Lamotrigine—epilepsy syndrome	5.68e-05	0.000246	CcSEcCtD
Cilazapril—Nervousness—Topiramate—epilepsy syndrome	5.66e-05	0.000246	CcSEcCtD
Cilazapril—Oedema—Gabapentin—epilepsy syndrome	5.66e-05	0.000245	CcSEcCtD
Cilazapril—Vomiting—Carbamazepine—epilepsy syndrome	5.65e-05	0.000245	CcSEcCtD
Cilazapril—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.62e-05	0.000244	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.62e-05	0.000244	CcSEcCtD
Cilazapril—Muscle spasms—Topiramate—epilepsy syndrome	5.61e-05	0.000243	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	5.61e-05	0.00103	CbGpPWpGaD
Cilazapril—Rash—Carbamazepine—epilepsy syndrome	5.6e-05	0.000243	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	5.6e-05	0.00102	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	5.6e-05	0.00102	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	5.6e-05	0.00102	CbGpPWpGaD
Cilazapril—Dermatitis—Carbamazepine—epilepsy syndrome	5.6e-05	0.000243	CcSEcCtD
Cilazapril—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.58e-05	0.000242	CcSEcCtD
Cilazapril—Insomnia—Pregabalin—epilepsy syndrome	5.58e-05	0.000242	CcSEcCtD
Cilazapril—Nausea—Clonazepam—epilepsy syndrome	5.57e-05	0.000241	CcSEcCtD
Cilazapril—Headache—Carbamazepine—epilepsy syndrome	5.57e-05	0.000241	CcSEcCtD
Cilazapril—Shock—Gabapentin—epilepsy syndrome	5.57e-05	0.000241	CcSEcCtD
Cilazapril—Paraesthesia—Pregabalin—epilepsy syndrome	5.54e-05	0.00024	CcSEcCtD
Cilazapril—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.54e-05	0.00024	CcSEcCtD
Cilazapril—Nausea—Phenytoin—epilepsy syndrome	5.53e-05	0.00024	CcSEcCtD
Cilazapril—Tachycardia—Gabapentin—epilepsy syndrome	5.52e-05	0.000239	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—epilepsy syndrome	5.51e-05	0.00101	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—epilepsy syndrome	5.51e-05	0.00101	CbGpPWpGaD
Cilazapril—Dyspnoea—Pregabalin—epilepsy syndrome	5.5e-05	0.000239	CcSEcCtD
Cilazapril—Nausea—Oxcarbazepine—epilepsy syndrome	5.5e-05	0.000239	CcSEcCtD
Cilazapril—Skin disorder—Gabapentin—epilepsy syndrome	5.49e-05	0.000238	CcSEcCtD
Cilazapril—Somnolence—Pregabalin—epilepsy syndrome	5.48e-05	0.000238	CcSEcCtD
Cilazapril—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.47e-05	0.000237	CcSEcCtD
Cilazapril—Tremor—Topiramate—epilepsy syndrome	5.46e-05	0.000237	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	5.46e-05	0.001	CbGpPWpGaD
Cilazapril—Vomiting—Lamotrigine—epilepsy syndrome	5.46e-05	0.000237	CcSEcCtD
Cilazapril—Urticaria—Valproic Acid—epilepsy syndrome	5.42e-05	0.000235	CcSEcCtD
Cilazapril—Rash—Lamotrigine—epilepsy syndrome	5.41e-05	0.000235	CcSEcCtD
Cilazapril—Ill-defined disorder—Topiramate—epilepsy syndrome	5.41e-05	0.000235	CcSEcCtD
Cilazapril—Dermatitis—Lamotrigine—epilepsy syndrome	5.41e-05	0.000235	CcSEcCtD
Cilazapril—Abdominal pain—Valproic Acid—epilepsy syndrome	5.39e-05	0.000234	CcSEcCtD
Cilazapril—Anorexia—Gabapentin—epilepsy syndrome	5.39e-05	0.000234	CcSEcCtD
Cilazapril—Anaemia—Topiramate—epilepsy syndrome	5.39e-05	0.000234	CcSEcCtD
Cilazapril—Headache—Lamotrigine—epilepsy syndrome	5.38e-05	0.000233	CcSEcCtD
Cilazapril—Decreased appetite—Pregabalin—epilepsy syndrome	5.36e-05	0.000233	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.33e-05	0.000231	CcSEcCtD
Cilazapril—Fatigue—Pregabalin—epilepsy syndrome	5.32e-05	0.000231	CcSEcCtD
Cilazapril—Hypotension—Gabapentin—epilepsy syndrome	5.29e-05	0.000229	CcSEcCtD
Cilazapril—Nausea—Carbamazepine—epilepsy syndrome	5.28e-05	0.000229	CcSEcCtD
Cilazapril—Constipation—Pregabalin—epilepsy syndrome	5.28e-05	0.000229	CcSEcCtD
Cilazapril—Pain—Pregabalin—epilepsy syndrome	5.28e-05	0.000229	CcSEcCtD
Cilazapril—Malaise—Topiramate—epilepsy syndrome	5.26e-05	0.000228	CcSEcCtD
Cilazapril—Vertigo—Topiramate—epilepsy syndrome	5.24e-05	0.000227	CcSEcCtD
Cilazapril—Syncope—Topiramate—epilepsy syndrome	5.23e-05	0.000227	CcSEcCtD
Cilazapril—Leukopenia—Topiramate—epilepsy syndrome	5.22e-05	0.000226	CcSEcCtD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—NOS2—epilepsy syndrome	5.19e-05	0.00095	CbGpPWpGaD
Cilazapril—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5.15e-05	0.000224	CcSEcCtD
Cilazapril—Palpitations—Topiramate—epilepsy syndrome	5.15e-05	0.000224	CcSEcCtD
Cilazapril—Loss of consciousness—Topiramate—epilepsy syndrome	5.13e-05	0.000222	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	5.12e-05	0.000937	CbGpPWpGaD
Cilazapril—Insomnia—Gabapentin—epilepsy syndrome	5.12e-05	0.000222	CcSEcCtD
Cilazapril—Nausea—Lamotrigine—epilepsy syndrome	5.1e-05	0.000221	CcSEcCtD
Cilazapril—Cough—Topiramate—epilepsy syndrome	5.09e-05	0.000221	CcSEcCtD
Cilazapril—Feeling abnormal—Pregabalin—epilepsy syndrome	5.08e-05	0.000221	CcSEcCtD
Cilazapril—Paraesthesia—Gabapentin—epilepsy syndrome	5.08e-05	0.00022	CcSEcCtD
Cilazapril—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.04e-05	0.000219	CcSEcCtD
Cilazapril—Dyspnoea—Gabapentin—epilepsy syndrome	5.04e-05	0.000219	CcSEcCtD
Cilazapril—Hypertension—Topiramate—epilepsy syndrome	5.03e-05	0.000218	CcSEcCtD
Cilazapril—Somnolence—Gabapentin—epilepsy syndrome	5.03e-05	0.000218	CcSEcCtD
Cilazapril—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.03e-05	0.000218	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	5.01e-05	0.000916	CbGpPWpGaD
Cilazapril—Dyspepsia—Gabapentin—epilepsy syndrome	4.98e-05	0.000216	CcSEcCtD
Cilazapril—Myalgia—Topiramate—epilepsy syndrome	4.96e-05	0.000215	CcSEcCtD
Cilazapril—Chest pain—Topiramate—epilepsy syndrome	4.96e-05	0.000215	CcSEcCtD
Cilazapril—Arthralgia—Topiramate—epilepsy syndrome	4.96e-05	0.000215	CcSEcCtD
Cilazapril—Anxiety—Topiramate—epilepsy syndrome	4.95e-05	0.000215	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.93e-05	0.000214	CcSEcCtD
Cilazapril—Decreased appetite—Gabapentin—epilepsy syndrome	4.92e-05	0.000213	CcSEcCtD
Cilazapril—Discomfort—Topiramate—epilepsy syndrome	4.9e-05	0.000213	CcSEcCtD
Cilazapril—Urticaria—Pregabalin—epilepsy syndrome	4.9e-05	0.000213	CcSEcCtD
Cilazapril—Asthenia—Valproic Acid—epilepsy syndrome	4.9e-05	0.000212	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.88e-05	0.000212	CcSEcCtD
Cilazapril—Fatigue—Gabapentin—epilepsy syndrome	4.88e-05	0.000212	CcSEcCtD
Cilazapril—Abdominal pain—Pregabalin—epilepsy syndrome	4.88e-05	0.000212	CcSEcCtD
Cilazapril—Dry mouth—Topiramate—epilepsy syndrome	4.86e-05	0.000211	CcSEcCtD
Cilazapril—Pain—Gabapentin—epilepsy syndrome	4.84e-05	0.00021	CcSEcCtD
Cilazapril—Constipation—Gabapentin—epilepsy syndrome	4.84e-05	0.00021	CcSEcCtD
Cilazapril—Pruritus—Valproic Acid—epilepsy syndrome	4.83e-05	0.000209	CcSEcCtD
Cilazapril—Confusional state—Topiramate—epilepsy syndrome	4.8e-05	0.000208	CcSEcCtD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—FOS—epilepsy syndrome	4.79e-05	0.000877	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	4.77e-05	0.000874	CbGpPWpGaD
Cilazapril—Oedema—Topiramate—epilepsy syndrome	4.76e-05	0.000206	CcSEcCtD
Cilazapril—Shock—Topiramate—epilepsy syndrome	4.68e-05	0.000203	CcSEcCtD
Cilazapril—Diarrhoea—Valproic Acid—epilepsy syndrome	4.67e-05	0.000203	CcSEcCtD
Cilazapril—Feeling abnormal—Gabapentin—epilepsy syndrome	4.66e-05	0.000202	CcSEcCtD
Cilazapril—Thrombocytopenia—Topiramate—epilepsy syndrome	4.66e-05	0.000202	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	4.65e-05	0.00085	CbGpPWpGaD
Cilazapril—Tachycardia—Topiramate—epilepsy syndrome	4.64e-05	0.000201	CcSEcCtD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	4.64e-05	0.000849	CbGpPWpGaD
Cilazapril—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.63e-05	0.000201	CcSEcCtD
Cilazapril—Skin disorder—Topiramate—epilepsy syndrome	4.62e-05	0.000201	CcSEcCtD
Cilazapril—Hyperhidrosis—Topiramate—epilepsy syndrome	4.6e-05	0.0002	CcSEcCtD
Cilazapril—Hypersensitivity—Pregabalin—epilepsy syndrome	4.54e-05	0.000197	CcSEcCtD
Cilazapril—Anorexia—Topiramate—epilepsy syndrome	4.54e-05	0.000197	CcSEcCtD
Cilazapril—Dizziness—Valproic Acid—epilepsy syndrome	4.51e-05	0.000196	CcSEcCtD
Cilazapril—Urticaria—Gabapentin—epilepsy syndrome	4.49e-05	0.000195	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	4.48e-05	0.000819	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—AGT—epilepsy syndrome	4.47e-05	0.000819	CbGpPWpGaD
Cilazapril—Abdominal pain—Gabapentin—epilepsy syndrome	4.47e-05	0.000194	CcSEcCtD
Cilazapril—Hypotension—Topiramate—epilepsy syndrome	4.45e-05	0.000193	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	4.43e-05	0.000811	CbGpPWpGaD
Cilazapril—Asthenia—Pregabalin—epilepsy syndrome	4.43e-05	0.000192	CcSEcCtD
Cilazapril—Pruritus—Pregabalin—epilepsy syndrome	4.36e-05	0.000189	CcSEcCtD
Cilazapril—Vomiting—Valproic Acid—epilepsy syndrome	4.34e-05	0.000188	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.34e-05	0.000188	CcSEcCtD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	4.31e-05	0.000788	CbGpPWpGaD
Cilazapril—Insomnia—Topiramate—epilepsy syndrome	4.3e-05	0.000187	CcSEcCtD
Cilazapril—Rash—Valproic Acid—epilepsy syndrome	4.3e-05	0.000187	CcSEcCtD
Cilazapril—Dermatitis—Valproic Acid—epilepsy syndrome	4.3e-05	0.000186	CcSEcCtD
Cilazapril—Headache—Valproic Acid—epilepsy syndrome	4.27e-05	0.000185	CcSEcCtD
Cilazapril—Paraesthesia—Topiramate—epilepsy syndrome	4.27e-05	0.000185	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	4.24e-05	0.000777	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	4.24e-05	0.000777	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	4.24e-05	0.000777	CbGpPWpGaD
Cilazapril—Dyspnoea—Topiramate—epilepsy syndrome	4.24e-05	0.000184	CcSEcCtD
Cilazapril—Somnolence—Topiramate—epilepsy syndrome	4.23e-05	0.000184	CcSEcCtD
Cilazapril—Diarrhoea—Pregabalin—epilepsy syndrome	4.22e-05	0.000183	CcSEcCtD
Cilazapril—Dyspepsia—Topiramate—epilepsy syndrome	4.19e-05	0.000182	CcSEcCtD
Cilazapril—Hypersensitivity—Gabapentin—epilepsy syndrome	4.17e-05	0.000181	CcSEcCtD
Cilazapril—Decreased appetite—Topiramate—epilepsy syndrome	4.14e-05	0.000179	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.11e-05	0.000178	CcSEcCtD
Cilazapril—Fatigue—Topiramate—epilepsy syndrome	4.1e-05	0.000178	CcSEcCtD
Cilazapril—Dizziness—Pregabalin—epilepsy syndrome	4.08e-05	0.000177	CcSEcCtD
Cilazapril—Pain—Topiramate—epilepsy syndrome	4.07e-05	0.000177	CcSEcCtD
Cilazapril—Constipation—Topiramate—epilepsy syndrome	4.07e-05	0.000177	CcSEcCtD
Cilazapril—Asthenia—Gabapentin—epilepsy syndrome	4.06e-05	0.000176	CcSEcCtD
Cilazapril—Nausea—Valproic Acid—epilepsy syndrome	4.05e-05	0.000176	CcSEcCtD
Cilazapril—ABCB1—Allograft Rejection—CASP8—epilepsy syndrome	4.05e-05	0.000742	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	4.05e-05	0.000741	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	4.05e-05	0.000741	CbGpPWpGaD
Cilazapril—Pruritus—Gabapentin—epilepsy syndrome	4e-05	0.000174	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.93e-05	0.000719	CbGpPWpGaD
Cilazapril—Vomiting—Pregabalin—epilepsy syndrome	3.92e-05	0.00017	CcSEcCtD
Cilazapril—Feeling abnormal—Topiramate—epilepsy syndrome	3.92e-05	0.00017	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.89e-05	0.000712	CbGpPWpGaD
Cilazapril—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.89e-05	0.000169	CcSEcCtD
Cilazapril—Rash—Pregabalin—epilepsy syndrome	3.89e-05	0.000169	CcSEcCtD
Cilazapril—Dermatitis—Pregabalin—epilepsy syndrome	3.89e-05	0.000169	CcSEcCtD
Cilazapril—Diarrhoea—Gabapentin—epilepsy syndrome	3.87e-05	0.000168	CcSEcCtD
Cilazapril—Headache—Pregabalin—epilepsy syndrome	3.86e-05	0.000168	CcSEcCtD
Cilazapril—Urticaria—Topiramate—epilepsy syndrome	3.78e-05	0.000164	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.77e-05	0.00069	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—POMC—epilepsy syndrome	3.77e-05	0.000689	CbGpPWpGaD
Cilazapril—Abdominal pain—Topiramate—epilepsy syndrome	3.76e-05	0.000163	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	3.75e-05	0.000686	CbGpPWpGaD
Cilazapril—Dizziness—Gabapentin—epilepsy syndrome	3.74e-05	0.000162	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—CCL2—epilepsy syndrome	3.69e-05	0.000675	CbGpPWpGaD
Cilazapril—Nausea—Pregabalin—epilepsy syndrome	3.66e-05	0.000159	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.65e-05	0.000667	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.61e-05	0.000661	CbGpPWpGaD
Cilazapril—Vomiting—Gabapentin—epilepsy syndrome	3.6e-05	0.000156	CcSEcCtD
Cilazapril—Rash—Gabapentin—epilepsy syndrome	3.57e-05	0.000155	CcSEcCtD
Cilazapril—Dermatitis—Gabapentin—epilepsy syndrome	3.56e-05	0.000155	CcSEcCtD
Cilazapril—Headache—Gabapentin—epilepsy syndrome	3.54e-05	0.000154	CcSEcCtD
Cilazapril—Hypersensitivity—Topiramate—epilepsy syndrome	3.51e-05	0.000152	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.5e-05	0.00064	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CA13—epilepsy syndrome	3.46e-05	0.000633	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—JUN—epilepsy syndrome	3.44e-05	0.00063	CbGpPWpGaD
Cilazapril—Asthenia—Topiramate—epilepsy syndrome	3.41e-05	0.000148	CcSEcCtD
Cilazapril—Pruritus—Topiramate—epilepsy syndrome	3.37e-05	0.000146	CcSEcCtD
Cilazapril—Nausea—Gabapentin—epilepsy syndrome	3.36e-05	0.000146	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	3.3e-05	0.000604	CbGpPWpGaD
Cilazapril—Diarrhoea—Topiramate—epilepsy syndrome	3.26e-05	0.000141	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	3.22e-05	0.000589	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	3.22e-05	0.000589	CbGpPWpGaD
Cilazapril—Dizziness—Topiramate—epilepsy syndrome	3.15e-05	0.000137	CcSEcCtD
Cilazapril—ABCB1—Allograft Rejection—IL1B—epilepsy syndrome	3.07e-05	0.000563	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	3.07e-05	0.000562	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CASP3—epilepsy syndrome	3.07e-05	0.000561	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	3.03e-05	0.000555	CbGpPWpGaD
Cilazapril—Vomiting—Topiramate—epilepsy syndrome	3.03e-05	0.000131	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	3.02e-05	0.000552	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—epilepsy syndrome	3e-05	0.00055	CbGpPWpGaD
Cilazapril—Rash—Topiramate—epilepsy syndrome	3e-05	0.00013	CcSEcCtD
Cilazapril—Dermatitis—Topiramate—epilepsy syndrome	3e-05	0.00013	CcSEcCtD
Cilazapril—Headache—Topiramate—epilepsy syndrome	2.98e-05	0.000129	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	2.94e-05	0.000538	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	2.94e-05	0.000538	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	2.94e-05	0.000538	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	2.94e-05	0.000538	CbGpPWpGaD
Cilazapril—Nausea—Topiramate—epilepsy syndrome	2.83e-05	0.000123	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	2.73e-05	0.000501	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GLUD1—epilepsy syndrome	2.62e-05	0.00048	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PDXK—epilepsy syndrome	2.62e-05	0.00048	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—FAR1—epilepsy syndrome	2.62e-05	0.00048	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CERS1—epilepsy syndrome	2.62e-05	0.00048	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ADK—epilepsy syndrome	2.62e-05	0.00048	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—L2HGDH—epilepsy syndrome	2.62e-05	0.00048	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	2.61e-05	0.000477	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—VEGFA—epilepsy syndrome	2.6e-05	0.000476	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	2.57e-05	0.000471	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	2.5e-05	0.000458	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	2.41e-05	0.000441	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GAMT—epilepsy syndrome	2.4e-05	0.000439	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PNPO—epilepsy syndrome	2.4e-05	0.000439	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—EPM2A—epilepsy syndrome	2.4e-05	0.000439	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NHLRC1—epilepsy syndrome	2.4e-05	0.000439	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.36e-05	0.000432	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	2.32e-05	0.000426	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.32e-05	0.000426	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	2.29e-05	0.000419	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	2.23e-05	0.000408	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CA4—epilepsy syndrome	2.23e-05	0.000408	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—QDPR—epilepsy syndrome	2.23e-05	0.000408	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.23e-05	0.000408	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.19e-05	0.000401	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—COX3—epilepsy syndrome	2.1e-05	0.000384	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.07e-05	0.000379	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	2e-05	0.000366	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.99e-05	0.000364	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.99e-05	0.000364	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.99e-05	0.000364	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.99e-05	0.000364	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.99e-05	0.000364	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.92e-05	0.000351	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.9e-05	0.000347	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.85e-05	0.000338	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.82e-05	0.000333	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.82e-05	0.000333	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.82e-05	0.000333	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.81e-05	0.000331	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.75e-05	0.00032	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.72e-05	0.000314	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	1.69e-05	0.000309	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GBE1—epilepsy syndrome	1.69e-05	0.000309	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.63e-05	0.000298	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.59e-05	0.000291	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.57e-05	0.000287	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—STXBP1—epilepsy syndrome	1.55e-05	0.000283	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.51e-05	0.000277	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NT5E—epilepsy syndrome	1.51e-05	0.000276	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALAD—epilepsy syndrome	1.51e-05	0.000276	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.5e-05	0.000274	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.47e-05	0.000269	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	1.44e-05	0.000263	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	1.44e-05	0.000263	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	1.41e-05	0.000257	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ADSL—epilepsy syndrome	1.38e-05	0.000252	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GLUL—epilepsy syndrome	1.35e-05	0.000247	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	1.33e-05	0.000243	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.32e-05	0.000241	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.28e-05	0.000235	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1.24e-05	0.000227	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.23e-05	0.000226	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.22e-05	0.000224	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AQP1—epilepsy syndrome	1.2e-05	0.00022	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.1e-05	0.000201	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	1.09e-05	0.000199	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CHRM3—epilepsy syndrome	1.09e-05	0.000199	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ABCG2—epilepsy syndrome	8.88e-06	0.000162	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	8.65e-06	0.000158	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	8.6e-06	0.000157	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	8.19e-06	0.00015	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	7.76e-06	0.000142	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.4e-06	0.000135	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	7.39e-06	0.000135	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—BCHE—epilepsy syndrome	7.36e-06	0.000135	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	7.02e-06	0.000128	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PLCB1—epilepsy syndrome	6.94e-06	0.000127	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—TH—epilepsy syndrome	6.92e-06	0.000127	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HMOX1—epilepsy syndrome	5.77e-06	0.000106	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CAT—epilepsy syndrome	5.69e-06	0.000104	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GPX1—epilepsy syndrome	5.15e-06	9.43e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AGT—epilepsy syndrome	4.52e-06	8.27e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—APOE—epilepsy syndrome	4.42e-06	8.1e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—POMC—epilepsy syndrome	3.8e-06	6.96e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALB—epilepsy syndrome	3.47e-06	6.34e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PTGS2—epilepsy syndrome	3.03e-06	5.55e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.52e-06	2.79e-05	CbGpPWpGaD
